Vancouver, British Columbia--(Newsfile Corp. - August 10, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency
and digital media network dedicated to legal cannabis, announces the publication of an article discussing True Leaf Medicine International Ltd. (CSE: MJ) (OTCQB: TRLFF) (FSE: TLA)
and its plans to capitalize on the multi-billion dollar cannabis industry through its two wholly-owned subsidiaries, True Leaf Pet
and True Leaf Medicine.
Click here to learn about the company's
upcoming Regulation A+ financing opportunity, and to receive an alert when it goes live.
Existing Revenue from True Leaf Pet
True Leaf's subsidiary, True Leaf Pet, is focused on the pet industry where its non-psychoactive hemp-based pet products are
already legal throughout the U.S., Canada, and Europe.
According to the American
Pet Products Association, Americans will spend nearly $70 billion on their pets this year. This spending includes about
$30 billion on food, $15 billion on over-the-counter medicine, and $16 billion on veterinary care products and services.
The company's True Hemp™ supplement line comes in multiple formats including chews, oil and sticks. It offers all
three formats in 3 specific functions:
|
●
|
True Hemp™ HIP+JOINT Support - Developed with hemp, green lipped mussel, and turmeric root to support joint
health.
|
|
●
|
True Hemp™ CALMING Support - Contain hemp, L-theanine, and calming herbs to help provide calming support to
pets.
|
|
●
|
True Hemp™ IMMUNE+HEART Support - Contain hemp, DHA, and other antioxidants to support heart and immune
health.
|
Management has developed manufacturing partnerships and distribution centers in the U.S., Canada, and Europe while continuing to
bolster its product line through a combination of internal development and potential acquisitions. The goal is to become a market
leader in the hemp + cannabis pet supplement industry as consumers become increasingly aware of the wonder-plant's potential to
support several medical conditions for pets.
Click here to learn about the company's
upcoming Regulation A+ financing opportunity, and to receive an alert when it goes live.
True Leaf Medicine: Long-term Potential as a Licensed Producer
True Leaf Medicine applied to become a licensed producer of dried cannabis flower under Canada's Access to Cannabis for Medical
Purposes Regulations (ACMPR) in July of 2013. Since then, the company has developed a plan to build a 48,000 square foot facility,
that is in the final stage of Health Canada's licensing process. Management anticipates generating upwards of $45 million in annual
revenue, when in full operations, starting next summer if it secures approval.
According to Deloitte, the Canadian cannabis industry could reach C$22.6 billion in size following the legalization of
recreational cannabis. The analyst expects the retail market to capture anywhere between C$4.9 billion and C$8.7 billion each year,
while the ancillary market for growers, testing labs, lighting, security, and other products could push the market to C$12.7
billion to C$22.6 billion. And, this doesn't include taxes, licensing, and tourism revenues.
Licensed producers have already generated tremendous interest among investors with several companies trading at lofty
valuations. True Leaf plans to develop products to support medical conditions like nausea, insomnia, chronic pain, and epilepsy
after securing its production and sales licenses. The company also has longer-term expansion plans for its production facility as
Canada's adult-use regulations kick in and the country becomes a leading exporter of cannabis products worldwide.
Please follow the link to see the interview and read the full article: LINK
Learn how to become a CFN Media featured company, brand or entrepreneur: http://www.cannabisfn.com/become-featured-company/
Download the CFN Media iOS mobile app to access the world of cannabis from your smart phone: https://itunes.apple.com/us/app/cannabisfn/id988009247?ls=1&mt=8
Or visit our homepage and enter your mobile number under the Apple App Store logo to receive a download link text on your
iPhone: http://www.cannabisfn.com
About CFN Media
CFN Media (CannabisFN) is the leading creative agency and media network dedicated to legal cannabis. We help marijuana
businesses attract investors, customers (B2B, B2C), capital, and media visibility. Private and public marijuana companies and
brands in the US and Canada rely on CFN Media to grow and succeed.
Disclaimer:
Except for the historical information presented herein, matters discussed in this release contain forward-looking statements
that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results,
performance or achievements expressed or implied by such statements. Emerging Growth LLC, which owns CFN Media and CannabisFN.com, is not registered with any financial or securities
regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release.
Emerging Growth LLC may from time to time have a position in the securities mentioned herein and may increase or decrease such
positions without notice. For making specific investment decisions, readers should seek their own advice. Emerging Growth LLC may
be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a
combination of the two. For full disclosure please visit: http://www.cannabisfn.com/legal-disclaimer/.
For more information, please see the Company's website at www.trueleaf.com.
Investor Contact:
Kevin Bottomley
Director and Corporate Relations
kevin@trueleaf.com
M: 778-389-9933
Media Contact:
Paul Sullivan
BreakThrough Communications
p.sullivan@breakthroughpr.com
O: 604-685-4742
M: 604-603-7358
